A phase I study of thalidomide for the treatment of plexiform neurofibroma in patients with neurofibromatosis 1 (NF1)

被引:0
|
作者
Gupta, A
Cohen, BH
Ruggieri, P
Packer, RJ
Phillips, P
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A12 / A13
页数:2
相关论文
共 50 条
  • [1] Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1
    Gupta, A
    Cohen, BH
    Ruggieri, P
    Packer, RJ
    Phillips, PC
    [J]. NEUROLOGY, 2003, 60 (01) : 130 - 132
  • [2] PREDICTORS OF PLEXIFORM NEUROFIBROMA (PN) GROWTH IN PATIENTS WITH NEUROFIBROMATOSIS 1 (NF1)
    Akshintala, Srivandana
    Dombi, Eva
    Baldwin, Andrea
    Gillespie, Andy
    Goodspeed, Wendy
    Goodwin, Anne
    Whitcomb, Patricia
    Steinberg, Seth
    Widemann, Brigitte
    [J]. PEDIATRIC BLOOD & CANCER, 2014, 61 : S32 - S33
  • [3] Radiosurgical treatment of ulnar plexiform neurofibroma in a neurofibromatosis type 1 (NF1) patient
    Marchetti, Marcello
    Franzini, Angelo
    Nazzi, Vittoria
    De Martin, Elena
    Fariselli, Laura
    [J]. ACTA NEUROCHIRURGICA, 2013, 155 (03) : 553 - 555
  • [4] Radiosurgical treatment of ulnar plexiform neurofibroma in a neurofibromatosis type 1 (NF1) patient
    Marcello Marchetti
    Angelo Franzini
    Vittoria Nazzi
    Elena De Martin
    Laura Fariselli
    [J]. Acta Neurochirurgica, 2013, 155 : 553 - 555
  • [5] Trametinib in pediatric patients with neurofibromatosis type 1 (NF-1)-associated plexiform neurofibroma: A phase I/IIa study.
    McCowage, Geoffrey Brian
    Mueller, Sabine
    Pratilas, Christine A.
    Hargrave, Darren R.
    Moertel, Christopher L.
    Whitlock, James
    Fox, Elizabeth
    Hingorani, Pooja
    Russo, Mark W.
    Dasgupta, Kohinoor
    Tseng, Lillian
    Mookerjee, Bijoyesh
    Geoerger, Birgit
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] CLINICAL BURDEN AMONG PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND PLEXIFORM NEUROFIBROMA (PN) IN THE UNITED STATES (US)
    Yang, Xiaoqin
    Yoo, Hyun Kyoo
    Amin, Suvina
    Cheng, Wendy
    Sipsma, Heather
    Sundaresan, Sanjana
    Zhang, Lujia
    Duh, Mei Sheng
    [J]. NEURO-ONCOLOGY, 2021, 23 : 41 - 42
  • [7] Personalized treatment in a boy with NF1 and inoperable plexiform orbital neurofibroma
    Trevisan, Valentina
    Viscogliosi, Germana
    Savino, Gustavo
    Salerni, Annabella
    Perri, Lucrezia
    Russo, Rosellina
    Benenati, Massimo
    Calandrelli, Rosalinda
    Onesimo, Roberta
    Giorgio, Valentina
    Rigante, Donato
    Genuardi, Maurizio
    Zampino, Giuseppe
    Leoni, Chiara
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 699 - 699
  • [8] Biallelic inactivation of NF1 in a sporadic plexiform neurofibroma
    Beert, Eline
    Brems, Hilde
    Renard, Marleen
    Ferreiro, Julio Finalet
    Melotte, Cindy
    Thoelen, Reinhilde
    De Wever, Ivo
    Sciot, Raf
    Legius, Eric
    Debiec-Rychter, Maria
    [J]. GENES CHROMOSOMES & CANCER, 2012, 51 (09): : 852 - 857
  • [9] Treatment for plexiform neurofibromas in patients with NF1
    Ardern-Holmes, Simone L.
    North, Kathryn N.
    [J]. LANCET ONCOLOGY, 2012, 13 (12): : 1175 - 1176
  • [10] Phase II pilot study of imatinib mesylate in neurofibromatosis (NF1) patients with plexiform neurofibromas.
    Robertson, K. A.
    Bowers, D. C.
    Yang, F.
    Vik, T.
    Ho, C.
    Croop, J.
    Walsh, L. E.
    Hingtgen, C.
    Pradhan, K. R.
    Hutchins, G.
    Fletcher, J. W.
    Cohen, M.
    Edwards-Brown, M.
    Travers, J. B.
    Yu, M.
    Nalepa, G.
    Denne, S.
    Ingram, D.
    Clapp, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)